ArticleMolecular diversity2026
Capsule enclosed coordinate attention based dual batch depthwise convolutional knowledge distillation model for drug-drug interaction prediction.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-drug interactions (DDIs) are a significant issue in drug discovery, impacting research efficiency and patient safety. Precise prediction of DDIs is important, particularly when drugs are co-administered. The combination of heterogeneous data sources that reflect drug relationships and properties can greatly enhance predictive accuracy. This paper proposes a new Capsule-enclosed Coordinate Attention-based Dual Batch Depthwise Convolutional Knowledge Distillation (CC-DBDKD) model for DDI prediction. The input data drawn from the DrugBank dataset is preprocessed with the RDKit to standardize SMILES strings into their canonical representations. Various techniques of molecular fingerprint generation, such as Extended Connectivity Fingerprints, MACCS keys, PubChem Fingerprints, 3D molecular fingerprints, and molecular dynamics fingerprints, are used to map drug chemical structures onto feature vectors. Drug similarities are subsequently calculated by the Tanimoto coefficient, and the Structural Similarity Profile (SSP) is calculated as an average of these fingerprint types. A lightweight model, CC-DBDKD, improves DDI prediction by introducing capsule networks to learn spatial hierarchies and complex drug relationships. Coordinate attention mechanisms improve feature extraction by attending to key interaction patterns. Adding dual-batch depthwise convolutional layers improves computational efficiency to support scalability with large datasets. In addition, knowledge distillation reinforces the model by mapping knowledge from a teacher model to a student model, enhancing accuracy and robustness. The proposed model realizes superior accuracy values of 0.987 and 0.989 and an F1-score of 0.986, which outshines other prevailing models like CNN, CNN-LSTM, Autoencoder, and D-CNN. The outcomes position the CC-DBDKD model as a strong and scalable instrument for accurate DDI prediction.
Indexed as
Identifiers
41533015What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.